Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
15
Frequently Asked Questions
What is Market Cap of Galectin Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Galectin Therapeutics Inc market cap is $344M.
What is the 52-week high for Galectin Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Galectin Therapeutics Inc 52 week high is $6.55 as of September 14, 2025.
What is the 52-week low for Galectin Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Galectin Therapeutics Inc 52 week low is $0.726 as of September 14, 2025.
What is Galectin Therapeutics Inc stock price today?
Galectin Therapeutics Inc stock price today is $5.37.
What was Galectin Therapeutics Inc stock price yesterday?
Galectin Therapeutics Inc stock price yesterday was $5.94.
What is the PE ratio of Galectin Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Galectin Therapeutics Inc’s P/E ratio is -8.34.
What is the Price-to-Book ratio of Galectin Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Galectin Therapeutics Inc P/B ratio is -2.8816.
What is the 50-day moving average of Galectin Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Galectin Therapeutics Inc 50-day moving average is $3.63.
How many employess does Galectin Therapeutics Inc has?